Repros Therapeutics

Repros reported additional topline results from study for Androxal
Yahoo/Fly on the Wall
Wed, 09/18/13 - 10:37 am
Androxal
Repros Therapeutics
testosterone
Repros Therapeutics: Winning The Battle But Losing The War?
Seeking Alpha
Tue, 09/17/13 - 09:34 am
Repros Therapeutics
AstraZeneca
Sanofi
Androxal
testosterone
Repros Therapeutics files IP rights action in Texas
The Fly on the Wall
Mon, 08/5/13 - 09:34 am
Repros Therapeutics
intellectual property
Androxal
5 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 05/25/13 - 12:38 pm
Alimera
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 05/18/13 - 12:24 pm
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 04/27/13 - 11:00 am
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sun, 04/21/13 - 10:42 am
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 04/13/13 - 12:20 pm
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 04/6/13 - 11:11 am
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Repros Therapeutics
Positive Data on Repros' Androxal
Yahoo/Zacks
Fri, 04/5/13 - 11:07 am
Repros Therapeutics
Androxal
secondary hypogonadism
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 03/30/13 - 10:38 am
Repros Therapeutics
Endocyte
Sarepta Therapeutics
Repros testosterone drug hits main goals of key study
Reuters
Thu, 03/28/13 - 10:31 am
Repros Therapeutics
testosterone
Androxal
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 03/23/13 - 10:06 am
Repros Therapeutics
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 03/9/13 - 12:45 pm
Repros Therapeutics
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Roche
Immunogen
Repros Therapeutics
Chelsea Therapeutics
Gilead Sciences
Vivus
Repros Therapeutics gets FDA go-ahead on testosterone drug study
Reuters
Thu, 02/21/13 - 12:10 pm
FDA
testosterone
Repros Therapeutics
Androxal
This Week in Biotech
Motley Fool
Sun, 02/3/13 - 11:23 am
Keryx
Vanda
Repros Therapeutics
Celsion
Zoetis
3 Questions for Roaring Repros
Motley Fool
Sat, 10/6/12 - 11:40 am
Repros Therapeutics
Earnings Miss at Repros
Yahoo/Zacks
Sat, 08/18/12 - 03:31 pm
Repros Therapeutics
earnings
A Closer Look At Repros Therapeutics
Seeking Alpha
Sun, 07/29/12 - 12:14 pm
Repros Therapeutics

Pages